348 related articles for article (PubMed ID: 26041152)
1. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
Sasongko TH; Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009191. PubMed ID: 26041152
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
Sasongko TH; Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
Sasongko TH; Nagalla S
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009191. PubMed ID: 34932828
[TBL] [Abstract][Full Text] [Related]
4. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
5. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia.
Foucan L; Bourhis V; Bangou J; Mérault L; Etienne-Julan M; Salmi RL
Am J Med; 1998 Apr; 104(4):339-42. PubMed ID: 9576406
[TBL] [Abstract][Full Text] [Related]
7. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
8. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
Asnani MR; Quimby KR; Bennett NR; Francis DK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
[TBL] [Abstract][Full Text] [Related]
9. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
11. Zinc supplements for treating thalassaemia and sickle cell disease.
Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
15. Treatment for avascular necrosis of bone in people with sickle cell disease.
Martí-Carvajal AJ; Solà I; Agreda-Pérez LH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004344. PubMed ID: 31803937
[TBL] [Abstract][Full Text] [Related]
16. Treatments for priapism in boys and men with sickle cell disease.
Chinegwundoh FI; Smith S; Anie KA
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004198. PubMed ID: 32251534
[TBL] [Abstract][Full Text] [Related]
17. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
[TBL] [Abstract][Full Text] [Related]
18. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
van Zuuren EJ; Fedorowicz Z
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
[TBL] [Abstract][Full Text] [Related]
20. Treatment for avascular necrosis of bone in people with sickle cell disease.
Martí-Carvajal AJ; Solà I; Agreda-Pérez LH
Cochrane Database Syst Rev; 2016 Aug; (8):CD004344. PubMed ID: 27502327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
